- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07293650
PREcision MEDicine In Achalasia (PREMEDIA) (PREMEDIA)
PREcision MEDicine In Achalasia - Een multicenter gerandomiseerde non-inferioriteits klinische studie van korte op maat gemaakte POEM versus standaard POEM voor niet-spastische achalasie en Een multicenter prospectieve cohortstudie van lange op maat gemaakte POEM voor spastische slokdarmmotiliteitsstoornissen
The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question[s] it aims to answer [is/are]:
- Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms?
- Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
The investigators will perform a randomized controlled trial to compare two different approaches to Peroral Endoscopic Myotomy (POEM) for treating achalasia (Types I and II) and esophagogastric junction outflow obstruction (EGJOO). The most widely used treatment for achalasia is POEM but the current approach involves a 9 cm (3.5 inch) myotomy (cutting of the muscle) to open up the tight lower esophageal sphincter to promote food delivery from the esophagus to the stomach. This approach is very effective, with success rates of approximately 90% over the short term. However, the investigators believe that POEM does not require a full 9 cm myotomy and that the investigators can cut much less muscle (approximately 4cm/1.25inches) to achieve similar improvement in symptoms but with less long-term complications. Cutting less muscle may result in less acid reflux, which is the Achilles heel of any successful treatment for achalasia. A shorter muscle cut may also result in less of a complication known as blown-out myotomy, which causes failure of the esophagus to empty its contents and is a major cause of long-term symptom relapse. The investigators have designed this study to determine whether the shorter myotomy (4 cm) is equivalent to the longer myotomy (9 cm) in terms if symptom improvement, but with the possibility of less acid reflux and blown-out myotomy.
Given these questions, the investigators will enroll 370 patients in a randomized trial where patients will receive either the short tailored (4cm/1.25 inches) or the standard myotomy (9cm/3.5 inches). All patients will undergo intraoperative assessment of success of the myotomy by using a special tool called the functional lumen imaging probe (FLIP). The FLIP will measure the opening dimensions of the lower esophageal sphincter and ensure that the myotomy is adequately performed so that the lower esophageal sphincter can open to a level that will improve esophageal emptying/swallowing. The investigators will follow patients for 2 years in a manner similar to how the investigators would follow patients after achalasia treatment in standard clinical practice. The investigators will assess whether symptoms are similar and whether or not there are differences in acid reflux and esophageal emptying. Patients will undergo follow up testing with questionnaires at intervals of 3-6 months over two years and they will have reflux testing (measure acid exposure using a capsule placed during endoscopy) between 6-12 months and a barium esophagram (X ray while drinking barium) at 2 years. The most important aim is to prove that the symptoms and outcomes success/failure) between the two approaches are similar (short myotomy is non-inferior) and the Eckardt score will be the primary questionnaire score for this study. The investigators believe that this study will help define the optimal approach to POEM in achalasia and also help us prevent complications in the future.
Additionally, the investigators will also ask participants to provide a sample of the muscle tissue that is typically cut during the POEM. This tissue will help us develop a tissue bank to help other researchers looking into the causes of why achalasia and these other esophageal diseases occur. The participants can opt out of this part and still continue in the randomized controlled trial.
Studietype
Inschrijving (Geschat)
Fase
- Fase 3
Contacten en locaties
Studiecontact
- Naam: Elizabeth Yan, BS
- Telefoonnummer: 312-908-1723
- E-mail: premedia.dcc@northwestern.edu
Studie Contact Back-up
- Naam: Yasmin Pina, BS
- Telefoonnummer: 312-503-6459
- E-mail: premedia.dcc@northwestern.edu
Studie Locaties
-
-
Arizona
-
Scottsdale, Arizona, Verenigde Staten, 85259
- Nog niet aan het werven
- Mayo Clinic Arizona
-
-
California
-
La Jolla, California, Verenigde Staten, 92037
- Werving
- University of California San Diego
-
Hoofdonderzoeker:
- Rena Yadlapati, MD
-
Contact:
- Alexander Gonsalves, Lead Study Coordinator
- Telefoonnummer: 858-246-5236
- E-mail: PREMEDIA@health.ucsd.edu
-
-
Colorado
-
Denver, Colorado, Verenigde Staten, 80217
- Nog niet aan het werven
- University of Colorado Denver
-
-
Florida
-
Gainesville, Florida, Verenigde Staten, 32611
- Werving
- University of Florida
-
Hoofdonderzoeker:
- Peter Draganov, MD
-
Contact:
- April Goddard, Lead Study Coordinator, PA-C
- Telefoonnummer: 352-273-9483
- E-mail: DOM-GIResereachTeam@ad.ufl.edu
-
Orlando, Florida, Verenigde Staten, 32803
- Nog niet aan het werven
- Adventist Health System/Sunbelt, Inc
-
-
Georgia
-
Atlanta, Georgia, Verenigde Staten, 30322
- Werving
- Emory University
-
Hoofdonderzoeker:
- Anand Jain, MD
-
Contact:
- Halley Fowler, Lead Study Coordinator
- Telefoonnummer: 404-778-3184
- E-mail: halley.fowler@emory.edu
-
-
Illinois
-
Chicago, Illinois, Verenigde Staten, 60611
- Werving
- Northwestern University
-
Hoofdonderzoeker:
- John Pandolfino, MD
-
Contact:
- Eric Pfannkuche, Lead Study Coordinator
- Telefoonnummer: 312-926-4525
- E-mail: PREMEDIA@northwestern.edu
-
-
Maryland
-
Baltimore, Maryland, Verenigde Staten, 21218
- Nog niet aan het werven
- Johns Hopkins University
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02114
- Werving
- Massachusetts General Hospital
-
Contact:
- Madison Paylor, Lead Study Coordinator
- Telefoonnummer: 617-726-0196
- E-mail: premedia@mgb.org
-
Hoofdonderzoeker:
- Kyle Staller, MD
-
-
Missouri
-
St Louis, Missouri, Verenigde Staten, 63110
- Werving
- Washington University
-
Contact:
- Darren Nix, Lead Study Coordinator
- Telefoonnummer: 314-273-1432
- E-mail: Premediasurgerytrial@wustl.edu
-
Hoofdonderzoeker:
- Chandra Gyawali, MD
-
-
New York
-
New York, New York, Verenigde Staten, 10065
- Nog niet aan het werven
- Weill Cornell Medical College
-
-
North Carolina
-
Charlotte, North Carolina, Verenigde Staten, 28204
- Werving
- Atrium Health/Wake Forest
-
Hoofdonderzoeker:
- Badih Elmunzer, MD
-
Contact:
- Greg Scarola, Lead Study Coordinator
- Telefoonnummer: (704) 355-2000
- E-mail: PREMEDIA@advocatehealth.org
-
-
Ohio
-
Cleveland, Ohio, Verenigde Staten, 44109
- Werving
- MetroHealth Medical Center
-
Hoofdonderzoeker:
- Ronnie Fass, MD
-
Contact:
- Stephanie Baker, Lead Study Coordinator
- Telefoonnummer: 216-778-5736
- E-mail: premedia@metrohealth.org
-
Cleveland, Ohio, Verenigde Staten, 44106
- Nog niet aan het werven
- Case Western Reserve University
-
-
Tennessee
-
Nashville, Tennessee, Verenigde Staten, 37232
- Werving
- Vanderbilt University Medical Center
-
Hoofdonderzoeker:
- Dhyanesh Patel, MD
-
Contact:
- Larry Raber, Lead Study Coordinator
- Telefoonnummer: 615-322-4643
- E-mail: larry.w.raber@vumc.org
-
-
Texas
-
Dallas, Texas, Verenigde Staten, 75246
- Werving
- Baylor Scott & White Health
-
Contact:
- Neomy Flores, Lead Study Coordinator
- Telefoonnummer: 214-820-9704
- E-mail: premedia@bswhealth.org
-
Hoofdonderzoeker:
- Vani Albertson Konda, MD
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria
- Age ≥ 18
- Type I achalasia or type II achalasia or cEGJOO
- Eckardt score > 3
Exclusion Criteria
The following exclusion criteria are for the RCT, but 1-13 below also pertain to the observational study:
- Prior POEM
- Prior surgical treatment for achalasia
- Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
- Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
- Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
- Known secondary achalasia related to malignancy (pseudoachalasia)
- Known eosinophilic esophagitis
- Diverticulum (> 2 cm) in distal esophagus
- Megaesophagus
- Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
- Pregnancy
- Standard contraindications to general anesthesia
- Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
- Unwillingness or inability to consent for the study
- Anticipated inability to follow protocol
- Weekly (or more frequent) opioid medication use in the last 2 years
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Verviervoudigen
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Standaard Myotomie
|
Myotomy during POEM of 8-10 cm in length, extending 2-3 cm into the gastric cardia; intention to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
|
Experimenteel: Op Maat Gemaakte Korte Myotomie
|
Myotomy during POEM of 4-5 cm in length, extending 1-2 cm into the gastric cardia; intend to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Clinical Response-Overall
Tijdsspanne: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Sex
Tijdsspanne: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Race
Tijdsspanne: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
|
Clinical Response-by Ethnicity
Tijdsspanne: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- PREMEDIA (Pro00083748) - 01
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- SAP
- MVO
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .